Hepatology
Ascites
New or worsening ascites requires prompt paracentesis, fluid-pattern interpretation, and early detection of spontaneous bacterial peritonitis, renal dysfunction, and portal-hypertensive decompensation. Management is driven by etiology, ascites severity, response to fluid removal, and candidacy for TIPS or liver transplantation.
Initial action
When ascites requires immediate diagnostic paracentesis
Do not attribute fluid accumulation to cirrhosis without fluid analysis.
Perform diagnostic paracentesis for all new-onset ascites. Obtain abdominal ultrasound before the procedure for fluid confirmation and site selection. In cirrhosis, perform the tap without delay at hospital admission and repeat diagnostic evaluation when ascites worsens or when gastrointestinal bleeding, shock, fever, systemic inflammation, gastrointestinal symptoms, worsening kidney or liver function, or hepatic encephalopathy occurs. Wiley+1WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Libraryeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Send ascitic fluid for cell count with differential, albumin, and total protein; obtain serum albumin on the same day for SAAG calculation. Send culture when infection is suspected, ideally by bedside inoculation into aerobic and anaerobic blood-culture bottles before antimicrobials. Cytology requires a larger sample than the approximately 50 mL generally sufficient for routine diagnostic studies. ScienceDirect+2ScienceDirectSerum-Ascites Albumin Gradient - an overviewScienceDirectPerforming Abdominal Paracentesis - ScienceDirectPubMedEvidence-based clinical practice guidelines for Liver Cirrhosis 2020
Ascites in cirrhosis is a decompensating event rather than an isolated symptom: five-year survival declines from approximately 80% in compensated cirrhosis to approximately 30% after ascites develops. Clinically significant ascites and associated complications should prompt consideration of liver-transplant evaluation. easl eu+1easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...aasldDiagnosis, Evaluation and Management of Ascites, Spontaneous ...
Use ultrasound-guided site selection when fluid is limited, loculated, or the bedside examination is uncertain. Wiley+1WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryScienceDirectPerforming Abdominal Paracentesis - ScienceDirect
During a therapeutic tap in a hospitalized patient, also request ascitic cell count because SBP may coexist with symptomatic volume overload. ScienceDirectScienceDirectPerforming Abdominal Paracentesis - ScienceDirect
If the drain is left in place, limit dwell time to 6 hours to reduce infection risk. ScienceDirectScienceDirectPerforming Abdominal Paracentesis - ScienceDirect
Fluid pattern
Use SAAG and ascitic protein to direct the etiologic workup
Classify portal-hypertensive versus nonportal ascites before committing to cirrhosis-directed therapy.
Calculate SAAG as serum albumin minus ascitic albumin. A SAAG ≥1.1 g/dL indicates portal hypertension and correlates with a hepatic vein–portal vein pressure gradient greater than 11 mm Hg; a SAAG <1.1 g/dL redirects the evaluation toward nonportal mechanisms. Although SAAG is highly useful, interpret it with the total clinical picture because exceptions occur. Wiley+1WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryPubMedEvidence-based clinical practice guidelines for Liver Cirrhosis 2020
For high-SAAG ascites, ascitic total protein is the key discriminator. A protein concentration <2.5 g/dL supports cirrhosis and portal hypertension, whereas protein ≥2.5 g/dL usually indicates right-heart failure. A high-SAAG result therefore should not automatically be labeled cirrhotic ascites when cardiac congestion is plausible. WileyWileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
For low-SAAG ascites, prioritize peritoneal malignancy, chronic peritoneal infection including tuberculosis, and nephrotic syndrome. Evaluate for nephrotic syndrome or protein-losing enteropathy when the clinical setting supports either diagnosis. Pancreatic ascites may produce an elevated PMN count but generally remains low-SAAG, so neutrophilia alone does not establish SBP in a nonportal fluid pattern. WileyWileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
Order ascitic cytology when a low-SAAG pattern or clinical course suggests peritoneal malignancy; malignant ascites reflects advanced malignant disease and may require repeated symptom-directed fluid management. JAMA+1JAMAMalignant Ascites: New Concepts in Pathophysiology, Diagnosis ...ScienceDirectPerforming Abdominal Paracentesis - ScienceDirect
In milky fluid, measure ascitic triglycerides and investigate malignancy, cirrhosis, postsurgical or traumatic lymphatic injury, and infection according to context. Chylous ascites is typically defined by triglycerides >200 mg/dL. ScienceDirect+1ScienceDirectIntranodal lymphangiography in the treatment of chylous ascites - ScienceDirectWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal
Use imaging to assess liver morphology, portal-hypertensive features, malignancy, pancreatic disease, or cardiac congestion in parallel with fluid classification; ultrasound is recommended before paracentesis. WileyWileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
Infection
Recognize and act on spontaneous bacterial peritonitis
The ascitic neutrophil count determines immediate management.
Diagnose SBP when ascitic fluid neutrophils exceed 250/mm3. This threshold applies whether neutrophils are measured microscopically or by flow cytometry-based automated counting; reagent strips do not have clear evidence for routine diagnosis. In a traumatic paracentesis with ascitic red cells >10,000/mm3, correct the PMN count by subtracting 1 PMN for every 250 red cells/mm3. ScienceDirect+1ScienceDirectSerum-Ascites Albumin Gradient - an overvieweasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Culture-negative neutrocytic ascites has PMN ≥250/mm3 with a negative culture and remains an infected-ascites phenotype requiring treatment. In contrast, monomicrobial nonneutrocytic bacterascites has a positive culture with PMN <250/mm3: treat symptomatic patients, but in asymptomatic patients repeat paracentesis and start antibiotics if the repeat PMN count reaches ≥250/mm3. ScienceDirectScienceDirectAscites - an overview | ScienceDirect Topics
In SBP with increased or rising serum creatinine, administer albumin 1.5 g/kg within 6 hours of diagnosis followed by 1 g/kg on day 3. This regimen targets the high-risk renal phenotype rather than routine albumin use for every infected ascites presentation. BMJ+2BMJGuidelines on the management of ascites in cirrhosis - GutBMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
Collect ascitic culture before antibiotics when feasible; bedside inoculation into aerobic and anaerobic bottles increases culture yield from approximately 50% to approximately 80% when PMN is ≥250/mm3. ScienceDirectScienceDirectSerum-Ascites Albumin Gradient - an overview
For healthcare-associated or nosocomial SBP, choose empiric therapy using local susceptibility data; piperacillin-tazobactam is suggested in settings with low multidrug resistance, while ESBL-prevalent settings may require a carbapenem, with additional gram-positive multidrug-resistant coverage considered where prevalent. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
If ascitic cultures are polymicrobial, consider procedural bowel puncture or another secondary intra-abdominal source rather than uncomplicated SBP. ScienceDirectScienceDirectAscites - an overview | ScienceDirect Topics
| Phenotype | Fluid findings | Management decision |
|---|---|---|
| SBP | PMN >250/mm3 | Treat as SBP; culture result does not delay treatment. easl eueasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ... |
| Culture-negative neutrocytic ascites | PMN ≥250/mm3 with negative culture | Manage as infected ascites requiring treatment. ScienceDirectScienceDirectAscites - an overview | ScienceDirect Topics |
| Monomicrobial nonneutrocytic bacterascites | Single-organism culture positive; PMN <250/mm3 | Treat if symptomatic; if asymptomatic, repeat paracentesis and treat if PMN becomes ≥250/mm3. ScienceDirectScienceDirectAscites - an overview | ScienceDirect Topics |
| Polymicrobial bacterascites | Multiple organisms; PMN <250/mm3 | Assess for needle-related gut puncture or another secondary source. ScienceDirectScienceDirectAscites - an overview | ScienceDirect Topics |
Volume management
Manage large-volume and refractory cirrhotic ascites
Paracentesis and albumin replacement are central when ascites is tense, symptomatic, or diuretic-refractory.
Large-volume paracentesis is standard care for large-volume ascites and is used with diuretic therapy when applicable. In diuretic-refractory ascites, remove as much fluid as feasible for symptom control. Bedside paracentesis is generally safe, and repeated therapeutic paracentesis is commonly used when fluid is refractory to fluid restriction and diuretics. BMJ+2BMJGuidelines on the management of ascites in cirrhosis - GutNEJMTreatment of Patients with CirrhosisScienceDirectPerforming Abdominal Paracentesis - ScienceDirect
After paracentesis removing >5 L, infuse 20% or 25% albumin at 8 g per liter of ascites removed. For removal of <5 L, consider the same 8 g/L replacement in acute-on-chronic liver failure or when post-paracentesis acute kidney injury risk is high. Albumin remains the preferred plasma expander in this setting. BMJ+1BMJGuidelines on the management of ascites in cirrhosis - GutBMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJ
Consider TIPS in selected patients with refractory or recurrent ascites, and assess transplant candidacy at the same decision point. TIPS may improve ascites control and, in more recent randomized studies using contemporary selection and stent approaches, improved survival compared with large-volume paracentesis; selection is crucial because the earlier trials commonly excluded more severe liver disease. BMJ+2BMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJBMJTransjugular intrahepatic portosystemic stent-shunt in the ... - GutNatureLiver diseases: epidemiology, causes, trends and predictions - Nature
Discuss TIPS with the transplant center before the procedure in transplant-eligible patients. BMJBMJTransjugular intrahepatic portosystemic stent-shunt in the ... - Gut
Treat bilirubin >50 micromol/L, platelets <75 × 10^9/L, current encephalopathy, active infection, progressive renal failure, severe systolic or diastolic dysfunction, and pulmonary hypertension as high-risk features that may predict limited TIPS benefit. BMJBMJTransjugular intrahepatic portosystemic stent-shunt in the ... - Gut
Monitor renal function, serum sodium, arterial pressure, and urine sodium because hyponatremia, low arterial pressure, increased creatinine, and low urine sodium predict poor prognosis in cirrhotic ascites. PubMedPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
Long-term albumin: selective and unsettled
Long-term albumin is not equivalent to post-paracentesis replacement. In the ANSWER trial of 442 patients with persistent ascites, 40 g human albumin weekly for up to 18 months was associated with a 38% lower mortality hazard and fewer refractory-ascites, renal, encephalopathy, and infection events. Its role across decompensated cirrhosis remains debated, so use should be individualized rather than substituted for evaluation of refractory ascites, TIPS suitability, or transplantation. BMJBMJchronic liver failure (ACLF) and the role of biomarkers - Gut
Beyond cirrhosis
Redirect management when ascites is nonportal or atypical
Fluid removal may relieve symptoms, but definitive control requires treating the driver.
A low-SAAG profile should prevent reflex escalation of portal-hypertension therapy. Peritoneal malignancy, chronic peritoneal infection, nephrotic syndrome, and pancreatic ascites each require a cause-specific diagnostic pathway; obtain cytology when malignancy is suspected, evaluate protein-loss disorders when indicated, and interpret pancreatic inflammation or leak in the setting of low-SAAG fluid. WileyWileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
Malignant ascites is associated with advanced cancer and significant morbidity. Use paracentesis for symptom relief and coordinate disease-directed oncologic assessment rather than treating the fluid pattern as cirrhotic ascites. Diuretics are described as a treatment mainstay, but the expected response depends on the underlying physiology and should not delay diagnostic clarification. JAMA+1JAMAMalignant Ascites: New Concepts in Pathophysiology, Diagnosis ...ScienceDirectPerforming Abdominal Paracentesis - ScienceDirect
For chylous ascites, distinguish lymphatic obstruction or leak from portal-hypertensive lymphatic overload. In adults in Western settings, tumors, cirrhosis, and postoperative leakage are common causes; lymphangiography may be a therapeutic option for refractory lymphatic leakage in selected cases. ScienceDirect+1ScienceDirectIntranodal lymphangiography in the treatment of chylous ascites - ScienceDirectWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal
Rapid fluid reaccumulation, low SAAG, atypical imaging, or milky fluid should trigger reassessment for malignancy or lymphatic pathology rather than repeated empiric cirrhosis-directed management. Wiley+2WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryScienceDirectIntranodal lymphangiography in the treatment of chylous ascites - ScienceDirectWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal
In suspected chylous ascites, triglycerides >200 mg/dL support the diagnosis but do not establish cause; actively exclude malignancy when nonportal etiologies are plausible. Wolters KluwerWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal
References
- Cirrhosis - Guidelines | BMJ Best Practice — bestpractice.bmj.com · bestpractice.bmj.com
- Guidelines on the management of ascites in cirrhosis - Gut — gut.bmj.com · gut.bmj.com
- Guidelines on the management of ascites in cirrhosis - Gut - The BMJ — gut.bmj.com · gut.bmj.com
- chronic liver failure (ACLF) and the role of biomarkers - Gut — gut.bmj.com · gut.bmj.com
- Treatment of Patients with Cirrhosis — www.nejm.org · www.nejm.org
- Transjugular intrahepatic portosystemic stent-shunt in the ... - Gut — gut.bmj.com · gut.bmj.com
- Does This Patient Have Ascites? How to Divine Fluid in the Abdomen — jamanetwork.com · jamanetwork.com
- Malignant Ascites: New Concepts in Pathophysiology, Diagnosis ... — jamanetwork.com · jamanetwork.com
- Liver diseases: epidemiology, causes, trends and predictions - Nature — www.nature.com · www.nature.com
- Unexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Serum-Ascites Albumin Gradient - an overview — www.sciencedirect.com · www.sciencedirect.com
- Performing Abdominal Paracentesis - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Ascites - an overview | ScienceDirect Topics — www.sciencedirect.com · www.sciencedirect.com
- The Epidemiology of Ascites in a Multi‐Ethnic Asian Population - Sinnanaidu - 2025 - JGH Open - Wiley Online Library — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Intranodal lymphangiography in the treatment of chylous ascites - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Chylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal — journals.lww.com · journals.lww.com
- Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- The AASLD Clinical Practice Guidelines: A Critical Review of Scientific Evidence and Evolving Recommendations - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- [PDF] EASL Clinical Practice Guidelines for the management of patients ... — easl.eu · easl.eu
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. - Abstract — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
- [PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL — easl.eu · easl.eu
- Cirrhosis & Complications Archives - EASL-The Home of Hepatology. — easl.eu · easl.eu
- Evidence-based clinical practice guidelines for Liver Cirrhosis 2020 — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Diagnosis, Evaluation and Management of Ascites, Spontaneous ... — www.aasld.org · www.aasld.org